Toward the end of trading Thursday, the Dow traded up 0.43% to 30,284.88 while the NASDAQ rose 0.70% to 12,747.11. The S&P also rose, gaining 0.54% to 3,721.00.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 16,980,840 cases with around 307,510 deaths. India confirmed a total of at least 9,956,550 confirmed cases and 144,450 deaths, while Brazil reported over 7,040,600 COVID-19 cases with 183,730 deaths. In total, there were at least 74,346,880 cases of COVID-19 worldwide with over 1,651,730 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Materials shares climbed 1.2% on Thursday. Meanwhile, top gainers in the sector included Turquoise Hill Resources Ltd. TRQ, up 13%, and Endeavour Silver Corp. EXK, up 11%.
In trading on Thursday, energy shares fell 0.5%.
Top Headline
Accenture plc CAN reported stronger-than-expected results for its first quarter on Thursday.
Accenture posted quarterly earnings of $2.17 per share, beating analysts’ estimates of $2.05 per share. The company’s quarterly sales came in at $11.76 billion, versus expectations of $11.36 billion.
Accenture said it expects Q2 sales of $11.55 billion to $11.95 billion, versus estimates of $11.35 billion. The company projects FY21 adjusted EPS of $8.02-$8.25, versus analysts’ expectations of $8.05.
Equities Trading UP
Scopus BioPharma Inc. SCPS shares shot up 498% to $35.38. Scopus BioPharma’s filing showed registration for 500,000 share common stock offering. Scopus Biopharma shares gained around 8% on Wednesday after the company priced its IPO at $5.5 per share.
Shares of MingZhu Logistics Holdings Limited YGMZ got a boost, shooting 185% to $11.41.
Wunong Net Technology Company Limited WNW shares were also up, gaining 87% to $122.00 after jumping 440% on Wednesday. The company, on Tuesday, priced its IPO at $5 per share.
Equities Trading DOWN
Triterras Inc TRIT shares tumbled 33% to $8.87 after confirming it informed a statutory demand for payment was made to Antanium Resources in Singapore. Triterras said in a regulatory filing it was informed that a statutory demand for payment from Antainium Resources (formerly known as Rhodium Resources) was filed by a creditor of Rhodium on Dec. 1.
Shares of BioCardia Inc BCDA were down 27% to $4.2406. BioCardia disclosed positive DSMB review and recommendation to continue Phase III pivotal CardiAMP heart failure study as designed. BioCardia recently reported a 1.789 million share registered direct offering priced at $4.75 per share.
SCYNEXIS, Inc. SCYX was down, falling 20% to $5.88 after the company reported the pricing of $85 million public offering of common stock, pre-funded warrants and warrants.
Commodities
In commodity news, oil traded up 1.3% to $48.43, while gold traded up 1.7% to $1,891.50.
Silver traded up 4.7% Thursday to $26.23 while copper rose 1.3% to $3.6055.
Euro zone
European shares closed mostly higher today. The eurozone’s STOXX 600 rose 0.3%, the Spanish Ibex Index rose 0.17%, while Italy’s FTSE MIB Index gained 0.12%. Meanwhile, the German DAX 30 gained 0.75%, French CAC 40 gained 0.03% and London’s FTSE 100 slipped 0.3%.
Eurozone consumer prices declined for a third straight month by 0.3% year-over-year in November, while French manufacturing climate indicator rose to 93 in December versus 92 in November.
Economics
US housing starts rose 1.2% to an annual rate of 1.547 million in November, while building permits rose 6.2% to 1.639 million.
US initial jobless claims climbed to 885,000 in the week ended December 12, versus a revised level of 862,000 in the prior week
The Philadelphia Fed manufacturing index declined to 11.1 in December versus 26.3 in November.
US natural-gas supplies dropped 122 billion cubic feet last week, the Energy Information Administration said.
The Kansas City Fed's manufacturing production index declined by 8 points to a reading of 12 in December.
Data on money supply for the recent week will be released at 4:30 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.